Clinical Evidence Compares Wegovy and Mounjaro Safety
Does Wegovy Have Fewer Side Effects Than Mounjaro in UK Clinical Data?
Clinical trials reveal both Wegovy and Mounjaro share similar side effect profiles, with gastrointestinal symptoms being most common for both medications. The STEP trials for Wegovy reported nausea in approximately 20% of patients, while Mounjaro's SURMOUNT studies showed comparable rates around 18-25% depending on the dose. Neither medication demonstrates a clear advantage in overall tolerability, as individual responses vary significantly based on personal factors including medical history, concurrent medications, and adherence to dose escalation schedules.
The question of whether Wegovy has less side effects than Mounjaro cannot be answered definitively without considering your specific circumstances. Both prescription-only medicines require careful monitoring and gradual dose increases to optimise tolerability. At EverydayMeds, our clinical team evaluates your medical history during the assessment to recommend the most appropriate option for your weight management journey.
Wegovy vs Mounjaro Pricing and Value Comparison
When considering does Wegovy have less side effects than Mounjaro, cost-effectiveness plays an important role in treatment decisions. Wegovy pricing at EverydayMeds starts with the 0.25mg starter dose at £79.99, progressing through 0.5mg (£94.99), 1mg (£99.99), 1.7mg (£139.99), to the 2.4mg maintenance dose at £209.99. Our Getting Started bundles provide convenient dose progression, with the Intro Duo (0.25mg & 0.5mg) priced at £169.99 for your first eight weeks of treatment.
New customers benefit from code FIRST40 applied at checkout, while returning customers use DOSE25 for continued savings. The three-pen Ultimate Stability Trio provides three months of 2.4mg maintenance supply for £649.99, ensuring uninterrupted treatment once you reach your optimal dose. Both Wegovy and Mounjaro are available from EverydayMeds, allowing your prescriber to help determine which medication aligns best with your tolerance profile and budget considerations.
Clinical Evidence on Wegovy vs Mounjaro Side Effect Profiles
The landmark STEP trials published by Wilding et al. in the New England Journal of Medicine (2021) provide comprehensive safety data for Wegovy. In clinical trials, patients taking Wegovy alongside diet and exercise reported discontinuation rates due to adverse events of approximately 7%, primarily due to gastrointestinal symptoms. The most frequently reported side effects included nausea, diarrhoea, vomiting, and constipation, typically occurring during dose escalation phases.
Mounjaro's SURMOUNT trials demonstrate similar safety patterns, with dual GIP/GLP-1 receptor activation producing comparable gastrointestinal effects. When evaluating does Wegovy have less side effects than Mounjaro, clinical evidence suggests both medications require similar precautions and monitoring. Individual tolerance varies significantly, making personalised prescriber assessment essential for determining the most suitable option for your circumstances.
How Wegovy Works Compared to Mounjaro's Mechanism
Understanding whether Wegovy has fewer side effects than Mounjaro requires knowledge of their different mechanisms of action. Wegovy contains semaglutide, a GLP-1 receptor agonist that mimics your body's natural incretin hormone, reducing appetite and promoting feelings of fullness after smaller meals. This single-target approach may result in more predictable side effect patterns, primarily affecting gastrointestinal function through delayed gastric emptying. Mounjaro contains tirzepatide, which acts on both GIP and GLP-1 receptors simultaneously, potentially creating a more complex side effect profile due to its dual mechanism. Both medications work on brain appetite centres to reduce food cravings, but their different receptor targets may influence individual tolerability. The question of does Wegovy have less side effects than Mounjaro often depends on how your body responds to single versus dual receptor activation.
Ordering Process for Wegovy vs Mounjaro Assessment
Determining whether Wegovy has fewer side effects than Mounjaro for your specific situation begins with our comprehensive 3-minute online clinical assessment. Our questionnaire evaluates your medical history, current medications, previous experiences with weight management treatments, and any gastrointestinal sensitivities that might influence medication selection. Following submission, our prescribers conduct a thorough review within 3 working days (or 24 hours with express service), specifically considering your tolerance profile when recommending between Wegovy and Mounjaro. Once approved, your medication arrives via next-day cold-chain delivery, maintaining the temperature-controlled storage essential for both treatments. Our GPhC-registered pharmacy (#9012878) ensures both options meet the highest UK pharmaceutical standards for quality and safety. The assessment process allows our clinical team to address the question of does Wegovy have less side effects than Mounjaro based on your individual medical circumstances rather than generalised comparisons.
Storage and Practical Considerations: Wegovy vs Mounjaro
When comparing does Wegovy have less side effects than Mounjaro, practical storage differences may influence your choice, particularly regarding travel and lifestyle flexibility. Wegovy pens maintain stability for up to 6 weeks at room temperature below 30°C once removed from refrigeration, compared to Mounjaro's 21-day room temperature limit. Both medications require standard refrigerator storage at 2-8°C before first use, utilising FlexTouch pen technology for once-weekly injection. The dose escalation schedule differs slightly between treatments, with Wegovy following a structured 4-week progression through 0.25mg, 0.5mg, 1mg, 1.7mg, before reaching 2.4mg maintenance dosing. This gradual increase helps minimise gastrointestinal side effects common to both medications, though individual responses vary. The extended room temperature stability of Wegovy may provide practical advantages for frequent travellers concerned about maintaining cold-chain storage, potentially reducing stress-related factors that might influence side effect perception.
UK-Specific Considerations for Wegovy vs Mounjaro Side Effect Comparison
British patients frequently ask does Wegovy have less side effects than Mounjaro when considering NICE-approved weight management options under current UK prescribing guidelines. Both medications received MHRA approval with specific monitoring requirements, including the Black Triangle (▼) designation indicating additional safety surveillance. UK clinical experience suggests neither medication demonstrates superior tolerability across the general population, with individual responses varying based on genetic factors, dietary habits, and concurrent health conditions common in British demographics.
The NHS recognition of both treatments through NICE guidance (TA875 for Wegovy) reflects equivalent safety profiles when prescribed alongside specialist weight management support. UK prescribers typically consider factors including patient preference for injection frequency, storage convenience, and previous GLP-1 agonist experience when determining whether Wegovy has fewer side effects than Mounjaro for individual patients. EverydayMeds' UK-based clinical team understands these nuanced considerations, providing personalised recommendations that align with British prescribing standards and patient expectations.
Making Your Choice: Wegovy or Mounjaro Assessment
The question of does Wegovy have less side effects than Mounjaro ultimately requires personalised medical evaluation rather than generalised comparisons. Clinical evidence demonstrates comparable safety profiles, with both medications requiring identical precautions including gradual dose escalation and dietary modifications to minimise gastrointestinal effects. Your prescriber will consider your medical history, previous medication experiences, lifestyle factors, and specific health goals when recommending the most suitable option. EverydayMeds provides expert assessment for both treatments, ensuring you receive evidence-based guidance tailored to your circumstances. Start your assessment today using code FIRST40 for new customers or DOSE25 for returning patients, with prices from £79.99 for initial doses. Both Wegovy and Mounjaro are available through our secure platform at https://everydaymeds.co.uk/collections/wegovy, backed by comprehensive prescriber support and next-day delivery throughout the UK.
Reviewed by the EverydayMeds Clinical Team · GPhC #9012878 · Last updated February 2026
